相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?
Michael N. Neely et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia
Younghee Jung et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
Natasha E. Holmes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Benchmarking Therapeutic Drug Monitoring Software: A Review of Available Computer Tools
Aline Fuchs et al.
CLINICAL PHARMACOKINETICS (2013)
Evaluation of Once-Daily Vancomycin against Methicillin-Resistant Staphylococcus aureus in a Hollow-Fiber Infection Model
Anthony M. Nicasio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization
Jack Brown et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Is Peak Concentration Needed in Therapeutic Drug Monitoring of Vancomycin? A Pharmacokinetic-Pharmacodynamic Analysis in Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia
Yosuke Suzuki et al.
CHEMOTHERAPY (2012)
Vancomycin: We Can't Get There from Here
Nimish Patel et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Validation of the Effectiveness of a Vancomycin Nomogram in Achieving Target Trough Concentrations of 15-20 mg/L Suggested by the Vancomycin Consensus Guidelines
Ravina Kullar et al.
PHARMACOTHERAPY (2011)
Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections
Elizabeth D. Hermsen et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2009)
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
M. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
T. P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia
Timothy C. Jenkins et al.
CLINICAL INFECTIOUS DISEASES (2008)
A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients
Jessina C. McGregor et al.
CLINICAL INFECTIOUS DISEASES (2007)
A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides
Mandy Wootton et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity
Levita K. Hidayat et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug'
GL Drusano
NATURE REVIEWS MICROBIOLOGY (2004)
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
PA Moise-Broder et al.
CLINICAL PHARMACOKINETICS (2004)
Clinical identifiers of complicated Staphylococcus aureus bacteremia
VG Fowler et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid
WA Craig
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2003)
Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia
TP Lodise et al.
CLINICAL INFECTIOUS DISEASES (2003)
Estimating the relative risk in cohort studies and clinical trials of common outcomes
LA McNutt et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus
SI Blot et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis
JS Li et al.
CLINICAL INFECTIOUS DISEASES (2000)
Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia
A Soriano et al.
CLINICAL INFECTIOUS DISEASES (2000)
分享论文
